Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
McKinsey
Deloitte
Harvard Business School
Cipla
Julphar
Accenture
Mallinckrodt

Generated: December 14, 2018

DrugPatentWatch Database Preview

Bromodiphenhydramine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bromodiphenhydramine hydrochloride and what is the scope of bromodiphenhydramine hydrochloride patent protection?

Bromodiphenhydramine hydrochloride is the generic ingredient in four branded drugs marketed by Parke Davis, Forest Labs, Alpharma Us Pharms, and Wockhardt, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for bromodiphenhydramine hydrochloride.

Summary for bromodiphenhydramine hydrochloride
Synonyms for bromodiphenhydramine hydrochloride
.beta.-(p-Bromobenzhydryloxy)ethyldimethylamine
.beta.-(p-Bromobenzhydryloxy)ethyldimethylamine hydrochloride
.beta.-[(p-Bromobenzhydryl)oxy]ethyldimethylamine hydrochloride
{2-[(4-bromophenyl)(phenyl)methoxy]ethyl}dimethylamine
{2-[(4-BROMOPHENYL)(PHENYL)METHOXY]ETHYL}DIMETHYLAZANIUM CHLORIDE
118-23-0
118-23-0 (Parent)
1808-12-4
1808-12-4 (hydrochloride)
2-((4-Bromophenyl)(phenyl)methoxy)-N,N-dimethylethanamine
2-((4-Bromophenyl)phenylmethoxy)ethyl(dimethyl)ammonium chloride
2-((p-Bromo-alpha-phenylbenzyl)oxy)-N,N-dimethylethylamine hydrochloride
2-(4-Bromobenzohydryloxy)-ethyl-dimethylamine hydrochloride
2-(4-Bromodiphenylmethoxy)ethyldimethylamine
2-(4-Bromodiphenylmethoxy)ethyldimethylamine Hydrochloride
2-(p-bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine
2-(p-bromo-alpha-phenylbenzyloxy)-N,N-dimethylethylamine hydrochloride
2-(p-Bromobenzhydryloxy)-N,N-dimethylethylamine hydrochloride
2-[(4-Bromobenzohydryl)oxy]ethyldimethylamine hydrochloride
2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine
2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine hydrochloride
2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine;hydrochloride
2-[(4-bromophenyl)-phenylmethoxy]ethyl-dimethylazanium chloride
2-[(4-Bromophenyl)(phenyl)methoxy]-N,N-dimethylethanamine
2-[(4-Bromophenyl)(phenyl)methoxy]-N,N-dimethylethanamine #
2-[(4-bromophenyl)(phenyl)methoxy]-N,N-dimethylethanamine hydrochloride
2-[(4-bromophenyl)(phenyl)methoxy]-N,N-dimethylethanamine hydrochloride (1:1)
2-[(4-bromophenyl)(phenyl)methoxy]-N,N-dimethylethanaminium chloride
2-[(4-Bromophenyl)phenylmethoxy]-N,N-dimethylethanamine Hydrochloride
2-[(p-Bromo-.alpha.-phenylbenzyl)oxy]-N,N-dimethylethylamine
2-[(p-Bromo-|A-phenylbenzyl)oxy]-N,N-dimethylethylamine Hydrochloride
2-[(RS)-(4-BROMOPHENYL) PHENYLMETHOXY]-N,NDIMETHYLETHANAMINE HYDROCHLORIDE (Bromodiphenhydramine Hydrochloride) (Diphenhydramine Impurity C), Pharmaceutical Secondary Standard; Certified Reference Material
2-[(RS)-(4-Bromophenyl)phenylmethoxy]-N,N-dimethylethanamine hydrochloride, pharmaceutical impurity standard
2-{[(4-bromophenyl)(phenyl)methyl]oxy}-N,N-dimethylethanamine
4-Bromo-.alpha.-phenylbenzyl 2-(dimethylamino)ethyl ether
4-Bromo-.alpha.-phenylbenzyl 2-dimethylaminoethyl ether
4-Bromo-alpha-phenylbenzyl 2-dimethylaminoethyl ether
4-Bromodiphenhydramine hydrochloride
AC1L1DOW
AC1L26IO
AC1LASIH
ACM118230
AK-47758
AKOS022179270
AKOS027382254
Ambodryl
Ambodryl hydrochloride
Ambrodyl (TN)
Amodryl
API0008908
BDBM81465
beta-(p-Bromobenzhydryloxy)ethyldimethylamine
beta-(p-Bromobenzhydryloxy)ethyldimethylamine hydrochloride
beta-dimethylaminoethyl p-bromobenzhydryl ether
Bromanautine
Bromanyl (TN)
Bromazin
Bromazin base
Bromazina
Bromazina [INN-Spanish]
Bromazine
Bromazine [INN:BAN]
bromazine HCl
Bromazine hydrochloride
Bromazine Hydrochloride 1.0 mg/ml in Methanol (as free base)
Bromazinum
Bromazinum [INN-Latin]
Bromdiphenhydramine
Bromdiphenhydramine hydrochloride
Bromdiphenhydraminum
Bromdiphenylhydramine hydrochloride
Bromo-Benadryl
Bromo-Benadryl base
Bromo-Benzdryl
Bromodiphen-hydramine
bromodiphenhydramine
BROMODIPHENHYDRAMINE HYDROCHLORIDE (200 MG)
Bromodiphenhydramine HCl
Bromodiphenhydramine hydrochloride (USP)
Bromodiphenhydramine hydrochloride [USP]
Bromodiphenhydramine hydrochloride, United States Pharmacopeia (USP) Reference Standard
C17H20BrNO
C17H20BrNO.HCl
CAS_2444
CAS-118-23-0
CHEBI:59177
CHEBI:59178
CHEMBL1200967
CHEMBL1201245
CTK8G6492
D03166
D0Y5GK
DB01237
Deserol
Deserol base
Diphenhydramine Impurity C HCl (Bromazine Hydrochloride)
DSSTox_CID_2688
DSSTox_GSID_22688
DSSTox_RID_97539
DTXSID6022688
EINECS 204-238-8
EINECS 217-310-9
Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride
Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochloride (9CI)
Ethanamine, 2-((4-bromophenyl)phenylmethoxy)-N,N-dimethyl-, hydrochoride
Ethanamine, 2-[(4-bromophenyl)phenylmethoxy]-N,N-dimethyl-
ETHYLAMINE, 2-((p-BROMO-alpha-PHENYLBENZYL)OXY)-N,N-DIMETHYL-, HYDROCHLORIDE
Ethylamine, 2-[(p-bromo-.alpha.-phenylbenzyl)oxy]-N,N-dimethyl-
FT-0663610
GTPL7132
Histabromamine
L001164
LS-172367
LS-67948
NCGC00249891-01
Neo-Benadryl
NSC 36113
NSC_2444
NSC-36113
NSC36113
NUNIWXHYABYXKF-UHFFFAOYSA-N
OR070675
OR207309
PDSP1_000145
PDSP2_000144
SCHEMBL141831
SCHEMBL29806
SR-01000944388
SR-01000944388-1
Tox21_113667
WLN: ER DYR&O2N1&1 &GH

US Patents and Regulatory Information for bromodiphenhydramine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms BROMANYL bromodiphenhydramine hydrochloride; codeine phosphate SYRUP;ORAL 088343-001 Aug 15, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt BROMODIPHENHYDRAMINE HYDROCHLORIDE AND CODEINE PHOSPHATE bromodiphenhydramine hydrochloride; codeine phosphate SYRUP;ORAL 088626-001 Oct 12, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Forest Labs AMBENYL bromodiphenhydramine hydrochloride; codeine phosphate SYRUP;ORAL 009319-006 Jan 10, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis AMBODRYL bromodiphenhydramine hydrochloride CAPSULE;ORAL 007984-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Cipla
UBS
Boehringer Ingelheim
Deloitte
Teva
Chinese Patent Office
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.